Francisco J Barrera-López, Maura E Noyola-García, Natalia G Barrera-López, Alejandra Albarrán-Sánchez
{"title":"三级医院毛霉菌病的外科和内科并发症。","authors":"Francisco J Barrera-López, Maura E Noyola-García, Natalia G Barrera-López, Alejandra Albarrán-Sánchez","doi":"10.24875/GMM.M25000988","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mucormycosis is an infection caused by Mucorales. Management includes surgical treatment and antifungals.</p><p><strong>Objective: </strong>To describe the surgical and medical complications associated with mucormycosis in a third-level hospital.</p><p><strong>Material and methods: </strong>Records of patients with mucormycosis treated between 2019 and 2022 were collected.</p><p><strong>Results: </strong>A total of 25 patients were obtained, 17 (68%) men and 8 (32%) women. Surgical complications occurred on admission in 16% and early in 4% of cases. The most frequent medical complications were soft tissue infection on admission (84%) and late sepsis (52%). Amphotericin B deoxycholate was used in all cases, finding hypokalemia in 20 (80%), hypomagnesemia in 18 (72%), and acute kidney injury in 15 (60%).</p><p><strong>Conclusions: </strong>The most commonly performed surgery was surgical debridement on admission (76%). Surgical complications occurred mainly on admission (16%). The most frequent medical complications were soft tissue infection on admission (84%) and late sepsis (52%). Due to the high cost of the liposomal and lipid forms of amphotericin, the use of amphotericin B deoxycholate continues to persist in our setting, which leads to a high degree of renal toxicity and hydroelectrolytic alterations.</p>","PeriodicalId":12736,"journal":{"name":"Gaceta medica de Mexico","volume":"161 2","pages":"148-153"},"PeriodicalIF":0.8000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Surgical and medical complications associated with mucormycosis in a tertiary hospital.\",\"authors\":\"Francisco J Barrera-López, Maura E Noyola-García, Natalia G Barrera-López, Alejandra Albarrán-Sánchez\",\"doi\":\"10.24875/GMM.M25000988\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Mucormycosis is an infection caused by Mucorales. Management includes surgical treatment and antifungals.</p><p><strong>Objective: </strong>To describe the surgical and medical complications associated with mucormycosis in a third-level hospital.</p><p><strong>Material and methods: </strong>Records of patients with mucormycosis treated between 2019 and 2022 were collected.</p><p><strong>Results: </strong>A total of 25 patients were obtained, 17 (68%) men and 8 (32%) women. Surgical complications occurred on admission in 16% and early in 4% of cases. The most frequent medical complications were soft tissue infection on admission (84%) and late sepsis (52%). Amphotericin B deoxycholate was used in all cases, finding hypokalemia in 20 (80%), hypomagnesemia in 18 (72%), and acute kidney injury in 15 (60%).</p><p><strong>Conclusions: </strong>The most commonly performed surgery was surgical debridement on admission (76%). Surgical complications occurred mainly on admission (16%). The most frequent medical complications were soft tissue infection on admission (84%) and late sepsis (52%). Due to the high cost of the liposomal and lipid forms of amphotericin, the use of amphotericin B deoxycholate continues to persist in our setting, which leads to a high degree of renal toxicity and hydroelectrolytic alterations.</p>\",\"PeriodicalId\":12736,\"journal\":{\"name\":\"Gaceta medica de Mexico\",\"volume\":\"161 2\",\"pages\":\"148-153\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gaceta medica de Mexico\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.24875/GMM.M25000988\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gaceta medica de Mexico","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.24875/GMM.M25000988","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Surgical and medical complications associated with mucormycosis in a tertiary hospital.
Background: Mucormycosis is an infection caused by Mucorales. Management includes surgical treatment and antifungals.
Objective: To describe the surgical and medical complications associated with mucormycosis in a third-level hospital.
Material and methods: Records of patients with mucormycosis treated between 2019 and 2022 were collected.
Results: A total of 25 patients were obtained, 17 (68%) men and 8 (32%) women. Surgical complications occurred on admission in 16% and early in 4% of cases. The most frequent medical complications were soft tissue infection on admission (84%) and late sepsis (52%). Amphotericin B deoxycholate was used in all cases, finding hypokalemia in 20 (80%), hypomagnesemia in 18 (72%), and acute kidney injury in 15 (60%).
Conclusions: The most commonly performed surgery was surgical debridement on admission (76%). Surgical complications occurred mainly on admission (16%). The most frequent medical complications were soft tissue infection on admission (84%) and late sepsis (52%). Due to the high cost of the liposomal and lipid forms of amphotericin, the use of amphotericin B deoxycholate continues to persist in our setting, which leads to a high degree of renal toxicity and hydroelectrolytic alterations.
期刊介绍：
Gaceta Médica de México México is the official scientific journal of the Academia Nacional de Medicina de México, A.C. Its goal is to contribute to health professionals by publishing the most relevant progress both in research and clinical practice.
Gaceta Médica de México is a bimonthly peer reviewed journal, published both in paper and online in open access, both in Spanish and English. It has a brilliant editorial board formed by national and international experts.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
